Oral bisphosphonate-related osteonecrosis of the jaw: Incidence, clinical features, prevention, and treatment recommendations

Clinical Reviews in Bone and Mineral Metabolism

Volumn 8, Issue 1, 2010, Pages 27-31

  Yarom, Noam ^a,b   Lazarovici, Towy Sorel ^a   Elad, Sharon ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alendronate; Bisphosphonates; Jaws; Osteonecrosis; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

CLINICAL FEATURE; DEBRIDEMENT; DRUG WITHDRAWAL; HUMAN; INCIDENCE; JAW OSTEONECROSIS; MOUTH INFECTION; PALLIATIVE THERAPY; PATHOGENESIS; REVIEW; RISK FACTOR; TOOTH EXTRACTION; TOOTH IMPLANTATION;

EID: 76149139413     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12018-009-9055-5     Document Type: Review

References (34)

1. RE Marx 2003 Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 1115 1117 10.1016/S0278-2391(03)00720-1 12966493 (Pubitemid 37064711)
2. J Wang NM Goodger MA Pogrel 2003 Osteonecrosis of the jaws associated with cancer chemotherapy J Oral Maxillofac Surg 61 1104 1107 10.1016/S0278-2391(03)00328-8 1:STN:280:DC%2BD3svisFOrug%3D%3D 12966490 (Pubitemid 37064708)
3. RE Marx Y Sawatari M Fortin V Broumand 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 1567 1575 10.1016/j.joms.2005.07.010 16243172 (Pubitemid 41525412)
4. SL Ruggiero B Mehrotra TJ Rosenberg SL Engroff 2004 Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 527 534 10.1016/j.joms.2004.02.004 15122554 (Pubitemid 38542516)
5. MC Farrugia DJ Summerlin E Krowiak T Huntley S Freeman R Borrowdale C Tomich 2006 Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 115 120 10.1097/01.mlg. 0000187398.51857.3c 16481822 (Pubitemid 44383974)
6. CA Migliorati MM Schubert DE Peterson LM Seneda 2005 Bisphosphonate- associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 83 93 10.1002/cncr.21130 1:CAS:528:DC%2BD2MXmtF2jtb4%3D 15929121 (Pubitemid 40847755)
7. PM Purcell IW Boyd 2005 Bisphosphonates and osteonecrosis of the jaw Med J Aust 182 417 418 15850440
8. B Shlomi Y Levy S Kleinman H Better A Kahn A Shtabsky G Chaushu 2005 Avascular necrosis of the jaw bone after bisphosphonate therapy Harefuah 144 536 539 16146148 (in Hebrew)
9. RE Marx JE Cillo JJ Ulloa 2007 Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment J Oral Maxillofac Surg 65 2397 2410 10.1016/j.joms.2007.08.003 18022461 (Pubitemid 350100982)
10. JK Brooks AJ Gilson AJ Sindler SG Ashman KG Schwartz NG Nikitakis 2007 Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 780 786 10.1016/j.tripleo.2006.10.010 17223592
11. N Yarom R Yahalom Y Shoshani W Hamed E Regev S Elad 2007 Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome Osteoporos Int 18 1363 1370 10.1007/s00198-007-0384-2 1:CAS:528:DC%2BD2sXhtVagurrI 17598065 (Pubitemid 47389465)
12. CA Migliorati BN Armonis O Nicolatou-Galitis 2008 Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 e18 e21 10.1016/j.tripleo.2008.03.005 18585606
13. PP Sedghizadeh K Stanley M Caligiuri S Hofkes B Lowry CF Shuler 2009 Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry J Am Dent Assoc 140 61 66 19119168
14. TS Lazarovici R Yahalom S Taicher S Elad I Hardan N Yarom 2009 Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 850 855 10.1016/j.joms.2008.11.015 19304045
15. T Hansen M Kunkel A Weber C James Kirkpatrick 2006 Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis J Oral Pathol Med 35 155 160 10.1111/j.1600-0714.2006.00391.x 16454811
16. ST Sonis BA Watkins GD Lyng MA Lerman KC Anderson 2009 Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients Oral Oncol 45 164 172 10.1016/j.oraloncology.2008.04.013 1:CAS:528: DC%2BD1MXhtVejurw%3D 18715819
17. MR Allen DB Burr 2009 The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data J Oral Maxillofac Surg 67 Suppl 5 61 70 10.1016/j.joms.2009.01.007 19371816
18. BG Durie M Katz J Crowley 2005 Osteonecrosis of the jaw and bisphosphonates N Engl J Med 353 99 102 10.1056/NEJM200507073530120 1:CAS:528:DC%2BD2MXmtVWgsLY%3D 16000365 (Pubitemid 41007817)
19. A Bamias E Kastritis C Bamia LA Moulopoulos I Melakopoulos G Bozas V Koutsoukou D Gika A Anagnostopoulos C Papadimitriou E Terpos MA Dimopoulos 2005 Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 8580 8587 10.1200/JCO.2005.02.8670 16314620 (Pubitemid 46211499)
20. AO Hoff BB Toth K Altundag MM Johnson CL Warneke M Hu A Nooka G Sayegh V Guarneri K Desrouleaux J Cui A Adamus RF Gagel GN Hortobagyi 2008 Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 826 836 10.1359/jbmr.080205 1:CAS:528:DC%2BD1cXnvVGjs70%3D 18558816 (Pubitemid 351768801)
21. American Dental Association Council on Scientific Affairs 2006 Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations J Am Dent Assoc 137 1144 1150
22. M Pazianas WA Blumentals PD Miller 2008 Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker Osteoporos Int 19 773 779 10.1007/s00198-007-0502-1 1:CAS:528: DC%2BD1cXltFyjtbo%3D 17999023
23. N Yarom S Elad 2008 Comment on Pazianas et al. Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker Osteoporos Int 19 849 850 10.1007/s00198-007-0546-2 18209945
24. T Mavrokokki A Cheng B Stein A Goss 2007 Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 415 423 10.1016/j.joms.2006.10.061 17307586 (Pubitemid 46343586)
25. MA Dimopoulos E Kastritis A Anagnostopoulos I Melakopoulos D Gika LA Moulopoulos C Bamia E Terpos K Tsionos A Bamias 2006 Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid Haematologica 91 968 971 1:CAS:528:DC%2BD28XnslSms78%3D 16757414
26. JH Wessel TB Dodson AI Zavras 2008 Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study J Oral Maxillofac Surg 66 625 631 10.1016/j.joms.2007.11.032 18355585
27. T Fehm V Beck M Banys HP Lipp M Hairass S Reinert EF Solomayer D Wallwiener M Krimmel 2009 Bisphosphonate-induced osteonecrosis of the jaw (ONJ): incidence and risk factors in patients with breast cancer and gynecological malignancies Gynecol Oncol 112 605 609 10.1016/j.ygyno.2008.11.029 1:CAS:528:DC%2BD1MXisVOhsr0%3D 19136147
28. MR Stumpe RK Chandra F Yunus S Samant 2009 Incidence and risk factors of bisphosphonate-associated osteonecrosis of the jaws Head Neck 31 202 206 10.1002/hed.20941 18853454
29. M Khamaisi E Regev N Yarom B Avni E Leitersdorf I Raz S Elad 2007 Possible association between diabetes and bisphosphonate-related jaw osteonecrosis J Clin Endocrinol Metab 92 1172 1175 10.1210/jc.2006-2036 1:CAS:528:DC%2BD2sXjtlGmsLc%3D 17179196 (Pubitemid 46465699)
30. S Elad N Yarom W Hamed S Ayalon R Yahalom E Regev 2006 Osteomyelitis and necrosis of the jaw in patients treated with bisphosphonates. A comparative study Clin Lab Haematol 28 393 398 10.1111/j.1365-2257.2006.00841.x 1:STN:280:DC%2BD28nmvV2jsw%3D%3D 17105493 (Pubitemid 44730204)
31. SL Ruggiero TB Dodson LA Assael R Landesberg RE Marx B Mehrotra American Association of Oral, Maxillofacial Surgeons 2009 American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update J Oral Maxillofac Surg 67 Suppl 5 2 12 19371809
32. MA Dimopoulos E Kastritis C Bamia I Melakopoulos D Gika M Roussou M Migkou E Eleftherakis-Papaiakovou D Christoulas E Terpos A Bamias 2009 Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid Ann Oncol 20 117 120 10.1093/annonc/mdn554 1:STN:280:DC%2BD1M%2Fns12hug%3D%3D 18689864
33. CI Ripamonti M Maniezzo T Campa E Fagnoni C Brunelli G Saibene C Bareggi L Ascani E Cislaghi 2009 Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan Ann Oncol 20 137 145 10.1093/annonc/mdn526 1:STN:280:DC%2BD1M%2Fns1ygug%3D%3D 18647964
34. T Hansen M Kunkel E Springer C Walter A Weber E Siegel CJ Kirkpatrick 2007 Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 1009 1017 10.1007/s00428-007-0516-2 17952459 (Pubitemid 350165265)